Cardiac Pacemaker Market - Trend, Growth, Forecast 2024–2032

Cardiac Pacemaker Market Synopsis:

Cardiac Pacemaker Market Size Was Valued at USD 5.39 Billion in 2023, and is Projected to Reach USD 8.08 Billion by 2032, Growing at a CAGR of 4.6% From 2024-2032.

The Cardiac Pacemaker Market means the industry which provides products in the sector of Cardiac Pacemaker Specifically, it refers to the business activities which designed, produced and sold Cardiac Pacemaker for patients with arrhythmias or Heart disorders. Pacemakers are devices that are implanted in the body to help it to maintain proper and steady heart beat rhythm. They include invasive devices that are surgically inserted internally, and non-invasive devices that are external to the body.

The market for cardiac pacemakers holds strong potential for vast growth because of increased instances of heart diseases and improvements in procedures. Therefore, with the current aging population internationally, the international demand for pacemakers will keep on increasing because, for each individual aged 65 and above, the chances of a heart problem like arrhythmias, heart block or atrial fibrillation are more likely. That is why the stock depends on the increase in cardiovascular disease knowledge and the popularity of pacemaker implantation as a therapy for heart arrhythmia.

The market is divided into two key segments: It’s safe to classify them into two; the Implantable pacemakers and the External pacemakers. The demand of implantable pacemakers which are placed internally outweigh those of externally worn devices because of their better and longer lasting efficiency. In implantable pacemakers, the market is segmented into single chamber, dual chamber, and biventricular pacemakers of which the dual chamber pacemaker is the most common. Most commonly, external pacemakers are used in emergent cases or for patients who cannot undergo placement of the implantable model.

The use of leadless pacemakers, wireless pacemakers, and smart pacemaker systems is revolutionalising the market. These innovations are strategies that seek to minimize the invasiveness of treatment for pacemakers, hasten their performance and enhance long distance remote monitoring. Market growth is also driven by today’s increasing health care expenditure and availability of better health care services in developed region. Though the factors like high costs of treatment, risks related to the implantation of pacemaker devices, and poor health care accessibility in the regions of the developing countries may hamper the growth of the concerned market.

Cardiac Pacemaker Market Trend Analysis:

Technological Advancements in Pacemaker Design

• Among the recent trends fostering the growth of the cardiac pacemaker market, one should mention further innovations in pacemaker construction, such as leadless pacemakers and wireless technologies. The old pacemaker involves lead (s) connecting the device to the heart while leadless pacemaker is compact, does not involve leads, and can be inserted through a catheter within the heart. This technology eliminates chances of getting specific complications including infection and formation of blood clot as compared to the conventional pacemakers.
• In addition Wireless pacemakers help care givers monitor a patient from a distance and also help monitor a patient’s heart rhythm, and even modify the pacemaker’s settings without having to visit the hospital. Such developments are most advantageous to patients who may require carriage by car which the elderly cannot easily undertake. Growing wireless technology is proving valuable by directly increased convenience, fewer hospital visits, as well as a better approach towards heart diseases.

Expanding Healthcare Access in Emerging Markets

• Another major attribute which point towards the potential in the cardiac pacemaker market is brought forth from the need among participants to extend the reach of healthcare to these emergent markets. Since the countries in Asia-Pacific, Africa, and Latin America are getting economically developed, the need for value-added medical devices such as pacemakers will likely to increase. Thus, governmental and healthcare organizations of these countries are focusing on the development and implementation of advanced facilities in the sphere of healthcare, as well as enhancing the access to medical technologies, raising the populations awareness of heart diseases and their management.
• The prospects for market development in these countries are very good. As disposable income gains ground, there are many patients with the ability to purchase pacemaker treatment. At the same time, the rise of cardiovascular diseases in these countries is considered a major opportunity for market participants interested in expanding their businesses and developing pacemaker products adapted to the local market. Thus, entering these emerging markets and forming strategic cooperation with healthcare facilities allows companies to address a huge and developing population.

Cardiac Pacemaker Market Segment Analysis:

Cardiac Pacemaker Market is Segmented on the basis of Product Type, Type, Application, End User, and Region

By Product Type, Implantable pacemakers’ segment is expected to dominate the market during the forecast period

• The cardiac pacemaker market can be divided into two major product categories: temporary pacemakers and permanent pacemakers. Pocket-paced makers are less common, but they are cardio pacemakers meant for long term use and can be kept buried within the patient’s body. These pacemakers work for longer periods and thus can cure the heart rhythm disorders and in some rescue cases, there is little that needs to be done to maintain their efficiency. Implantable pacemakers are of different classifications: atrial, ventricular and dual-chambered and biventricular implantable pacemakers. The kind that is most prevalent is the dual-chamber pacemaker that assists in controlling both the upper chamber or the atrium and the lower chamber or the ventricle of the heart hence providing a more ordered approach of handling the market’s patients with irregular heabe.
• In contrast, external pacemakers are utilized when the intrinsic impulse generation is abnormal and in emergency situations or only for the short-term therapy of cardiovascular dysrhythmias. These pacemakers are not suture to the body and can be worn outside the body to regulate the rate of the heartbeat until the permanent solution is made. However, external pacemakers are not as popular as implantable devices; nevertheless, they have a definite place and duties in a critical care setting.

By Application, Arrhythmias segment expected to held the largest share

• The first type of treatment of this product is for rhythms disorders, atrial fibrillation, heart block, long QT syndromes, and congestive heart failure. Heart failure is one of the major consumers of pacemakers and the most frequent type of disease is arrhythmia that is an irregular heartbeat. Pacemakers assist in regulating the normal rhythms of the heart and, in so doing, promotes pumping. The second key application is atrial fibrillation, which is an irregular electrical activity in the atria and in many cases cause blood clots, stroke, etc. pacemakers are implanted to control the electrical signals of the heart eliminating these risks.
• Other applications include heart block, long QT syndrome and congestive heart failure – all of which make a contribution to the need for pacemakers. Heart block describes a delay in the pathway of electrical signals in the heart, whereas long QT syndrome is a disorder of the electrical processes of the heart that may predispose to fatal arrhythmias. Pacemakers are crucial to address these conditions by helping regulate normal and steady heartbeats, and lessening the chance of an untoward cardiac arrest. Moreso, as these diseases continue to gain momentum throughout the globe, there will be a upsurge in the need for pacemaker solutions.

Cardiac Pacemaker Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• Thus, North America is the largest market for cardiac pacemaker, mainly because of developed healthcare system, increased Health Care expenditure and rising incidences of cardiovascular diseases. The region has adopted sound health standards to enhance the implementation of new generation medical technologies such as pacemaker. The presence of the key manufacturers like Medtronic and Abbott has led to the North America to gain a stronger market.
• There is also an increased pressure as a result of population aging leading to increased rate of occurrences of heart related ailments that require pacemakers. Besides, the raising knowledge about heart disease, the enhanced possibility to get the healthcare and insurance services, are the factors that influence the popularity of pacemakers in North America. This dominance is anticipated to persist due to the current advancements in pacemaker technologies, and a rising overall commitment to the healthcare segment focused on enhancing cardiovascular therapy.

Active Key Players in the Cardiac Pacemaker Market:

• Medtronic (Ireland)
• Abbott Laboratories (USA)
• Boston Scientific (USA)
• Biotronik (Germany)
• St. Jude Medical (USA)
• Philips Healthcare (Netherlands)
• Sorin Group (Italy)
• MicroPort Scientific Corporation (China)
• Osypka Medical (Germany)
• Lepu Medical Technology (China)
• Cook Medical (USA)
• Medico S.p.A (Italy)
• Other Active Players

Key Industry Developments in the Cardiac Pacemaker Market:

• In July 2023, Abbott, a medical device company, announced that the U.S. Food and Drug Administration (FDA) had approved the AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. Leadless pacemakers provide a new minimally invasive option that will revolutionize care for more people in the U.S. who need pacing to treat a variety of slow or abnormal heart rhythms.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Cardiac Pacemaker Market by Product Type
 4.1 Cardiac Pacemaker Market Snapshot and Growth Engine
 4.2 Cardiac Pacemaker Market Overview
 4.3 Implantable Pacemakers
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Implantable Pacemakers: Geographic Segmentation Analysis
 4.4 Single Chamber
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Single Chamber: Geographic Segmentation Analysis
 4.5 Dual Chamber
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Dual Chamber: Geographic Segmentation Analysis
 4.6 Biventricular Chamber
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Biventricular Chamber: Geographic Segmentation Analysis
 4.7 External Pacemakers
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 External Pacemakers: Geographic Segmentation Analysis

Chapter 5: Cardiac Pacemaker Market by Type
 5.1 Cardiac Pacemaker Market Snapshot and Growth Engine
 5.2 Cardiac Pacemaker Market Overview
 5.3 MRI Compatible Pacemakers
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 MRI Compatible Pacemakers: Geographic Segmentation Analysis
 5.4 Conventional Pacemakers
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Conventional Pacemakers: Geographic Segmentation Analysis

Chapter 6: Cardiac Pacemaker Market by Application
 6.1 Cardiac Pacemaker Market Snapshot and Growth Engine
 6.2 Cardiac Pacemaker Market Overview
 6.3 Arrhythmias
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Arrhythmias: Geographic Segmentation Analysis
 6.4 Atrial Fibrillation
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Atrial Fibrillation: Geographic Segmentation Analysis
 6.5 Heart Block
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Heart Block: Geographic Segmentation Analysis
 6.6 Long QT Syndrome
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Long QT Syndrome: Geographic Segmentation Analysis
 6.7 Congestive Heart Failure
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Congestive Heart Failure: Geographic Segmentation Analysis
 6.8 Others
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Others: Geographic Segmentation Analysis

Chapter 7: Cardiac Pacemaker Market by End-Use
 7.1 Cardiac Pacemaker Market Snapshot and Growth Engine
 7.2 Cardiac Pacemaker Market Overview
 7.3 Hospitals & Cardiac Centers
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals & Cardiac Centers: Geographic Segmentation Analysis
 7.4 Ambulatory Surgical Centers
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
 7.5 Others
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Cardiac Pacemaker Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 MEDTRONIC (IRELAND)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 ABBOTT LABORATORIES (USA)
 8.4 BOSTON SCIENTIFIC (USA)
 8.5 BIOTRONIK (GERMANY)
 8.6 ST. JUDE MEDICAL (USA)
 8.7 PHILIPS HEALTHCARE (NETHERLANDS)
 8.8 SORIN GROUP (ITALY)
 8.9 MICROPORT SCIENTIFIC CORPORATION (CHINA)
 8.10 OSYPKA MEDICAL (GERMANY)
 8.11 LEPU MEDICAL TECHNOLOGY (CHINA)
 8.12 COOK MEDICAL (USA)
 8.13 MEDICO S.P.A (ITALY)
 8.14 OTHER ACTIVE PLAYERS

Chapter 9: Global Cardiac Pacemaker Market By Region
 9.1 Overview
 9.2. North America Cardiac Pacemaker Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Implantable Pacemakers
  9.2.4.2 Single Chamber
  9.2.4.3 Dual Chamber
  9.2.4.4 Biventricular Chamber
  9.2.4.5 External Pacemakers
  9.2.5 Historic and Forecasted Market Size By Type
  9.2.5.1 MRI Compatible Pacemakers
  9.2.5.2 Conventional Pacemakers
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Arrhythmias
  9.2.6.2 Atrial Fibrillation
  9.2.6.3 Heart Block
  9.2.6.4 Long QT Syndrome
  9.2.6.5 Congestive Heart Failure
  9.2.6.6 Others
  9.2.7 Historic and Forecasted Market Size By End-Use
  9.2.7.1 Hospitals & Cardiac Centers
  9.2.7.2 Ambulatory Surgical Centers
  9.2.7.3 Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Cardiac Pacemaker Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Implantable Pacemakers
  9.3.4.2 Single Chamber
  9.3.4.3 Dual Chamber
  9.3.4.4 Biventricular Chamber
  9.3.4.5 External Pacemakers
  9.3.5 Historic and Forecasted Market Size By Type
  9.3.5.1 MRI Compatible Pacemakers
  9.3.5.2 Conventional Pacemakers
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Arrhythmias
  9.3.6.2 Atrial Fibrillation
  9.3.6.3 Heart Block
  9.3.6.4 Long QT Syndrome
  9.3.6.5 Congestive Heart Failure
  9.3.6.6 Others
  9.3.7 Historic and Forecasted Market Size By End-Use
  9.3.7.1 Hospitals & Cardiac Centers
  9.3.7.2 Ambulatory Surgical Centers
  9.3.7.3 Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
 9.4. Western Europe Cardiac Pacemaker Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Implantable Pacemakers
  9.4.4.2 Single Chamber
  9.4.4.3 Dual Chamber
  9.4.4.4 Biventricular Chamber
  9.4.4.5 External Pacemakers
  9.4.5 Historic and Forecasted Market Size By Type
  9.4.5.1 MRI Compatible Pacemakers
  9.4.5.2 Conventional Pacemakers
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Arrhythmias
  9.4.6.2 Atrial Fibrillation
  9.4.6.3 Heart Block
  9.4.6.4 Long QT Syndrome
  9.4.6.5 Congestive Heart Failure
  9.4.6.6 Others
  9.4.7 Historic and Forecasted Market Size By End-Use
  9.4.7.1 Hospitals & Cardiac Centers
  9.4.7.2 Ambulatory Surgical Centers
  9.4.7.3 Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
 9.5. Asia Pacific Cardiac Pacemaker Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Implantable Pacemakers
  9.5.4.2 Single Chamber
  9.5.4.3 Dual Chamber
  9.5.4.4 Biventricular Chamber
  9.5.4.5 External Pacemakers
  9.5.5 Historic and Forecasted Market Size By Type
  9.5.5.1 MRI Compatible Pacemakers
  9.5.5.2 Conventional Pacemakers
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Arrhythmias
  9.5.6.2 Atrial Fibrillation
  9.5.6.3 Heart Block
  9.5.6.4 Long QT Syndrome
  9.5.6.5 Congestive Heart Failure
  9.5.6.6 Others
  9.5.7 Historic and Forecasted Market Size By End-Use
  9.5.7.1 Hospitals & Cardiac Centers
  9.5.7.2 Ambulatory Surgical Centers
  9.5.7.3 Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Cardiac Pacemaker Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Implantable Pacemakers
  9.6.4.2 Single Chamber
  9.6.4.3 Dual Chamber
  9.6.4.4 Biventricular Chamber
  9.6.4.5 External Pacemakers
  9.6.5 Historic and Forecasted Market Size By Type
  9.6.5.1 MRI Compatible Pacemakers
  9.6.5.2 Conventional Pacemakers
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Arrhythmias
  9.6.6.2 Atrial Fibrillation
  9.6.6.3 Heart Block
  9.6.6.4 Long QT Syndrome
  9.6.6.5 Congestive Heart Failure
  9.6.6.6 Others
  9.6.7 Historic and Forecasted Market Size By End-Use
  9.6.7.1 Hospitals & Cardiac Centers
  9.6.7.2 Ambulatory Surgical Centers
  9.6.7.3 Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Cardiac Pacemaker Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Implantable Pacemakers
  9.7.4.2 Single Chamber
  9.7.4.3 Dual Chamber
  9.7.4.4 Biventricular Chamber
  9.7.4.5 External Pacemakers
  9.7.5 Historic and Forecasted Market Size By Type
  9.7.5.1 MRI Compatible Pacemakers
  9.7.5.2 Conventional Pacemakers
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Arrhythmias
  9.7.6.2 Atrial Fibrillation
  9.7.6.3 Heart Block
  9.7.6.4 Long QT Syndrome
  9.7.6.5 Congestive Heart Failure
  9.7.6.6 Others
  9.7.7 Historic and Forecasted Market Size By End-Use
  9.7.7.1 Hospitals & Cardiac Centers
  9.7.7.2 Ambulatory Surgical Centers
  9.7.7.3 Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research